NIH Funding and Disease Burden Analysis
Author Information
Author(s): Gillum Leslie A., Gouveia Christopher, Dorsey E. Ray, Pletcher Mark, Mathers Colin D., McCulloch Charles E., Johnston S. Claiborne
Primary Institution: University of California San Francisco
Hypothesis
Has the association between current burden and NIH funding changed since the 1998 IOM recommendations?
Conclusion
Current levels of NIH disease-specific research funding correlate modestly with US disease burden, and correlation has not improved in the last decade.
Supporting Evidence
- NIH funding levels increased with burden of disease measured in DALYs.
- Only 33% of NIH funding variance was explained by disease burden in 2006.
- Conditions receiving the most funding greater than expected based on disease burden included AIDS and diabetes mellitus.
- Depression and injuries were among the most underfunded conditions.
Takeaway
The study looked at how well NIH funding matches the burden of diseases in the US, finding that it doesn't match very well and hasn't improved over the years.
Methodology
Analyzed public data on NIH funding for 29 common conditions and assessed the relationship between disease burden and funding in univariate and multivariable models.
Potential Biases
Potential influence of public interest and lobbying on funding levels.
Limitations
The accounting of disease funding by NIH is not standardized, and many diseases were omitted from the analysis.
Participant Demographics
Conditions analyzed included a variety of diseases affecting the US population.
Statistical Information
P-Value
0.001
Confidence Interval
(1.16–1.63)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website